Sector: MedicalOSIRIS THERAPEUTICS (NASDAQ: OSIR)
Headlines
- Osiris Therapeutics Achieves $15 Million Milestone Payment
Nov 03, 2009 07:30 AM | OSIR
- Integrity Media: Stem Cell Report Released
Oct 30, 2009 10:01 AM | ASTM, OSIR
- Osiris Therapeutics Announces Third Quarter 2009 Financial Results Conference Call
Oct 23, 2009 09:00 AM | OSIR
- Osiris Therapeutics to Present at Fourth Annual JMP Securities Healthcare Focus Conference
Sep 30, 2009 08:30 AM | OSIR
- StockPreacher.com Issues Cautious Trading Outlook for Osiris Therapeutics Inc.
Sep 24, 2009 06:52 AM | BIIB, CYTX, GENZ, OSIR
- 5th Annual Stem Cell Summit Set for Feb. 16 in New York City
Sep 23, 2009 11:41 AM | ASTM, ATHX, OSIR, PSTI
- OSIR: This Company’s Failure Clears Your Path To Real Stem Cell Fortunes
Sep 18, 2009 02:49 PM | OSIR
- StockPreacher.com Issues Technical Trading Overview for StemCells Inc.
Sep 15, 2009 06:52 AM | ASTM, GERN, OSIR
- Osiris Therapeutics to Present at ThinkEquity and UBS Conferences
Sep 11, 2009 05:44 PM | OSIR, UBS
- Osiris Therapeutics Announces Preliminary Results for Prochymal Phase III GvHD Trials
Sep 08, 2009 08:02 AM | OSIR
- Stem cell drug fails clinical tests
Sep 09, 2009 07:11 PM | OSIR
- Stem cell drug fails clinical tests
Sep 09, 2009 08:40 AM | OSIR
- GE, Kraft, Atheros, Harley-Davidson big movers
Sep 08, 2009 06:10 PM | ATHR, C, GE, HL, HOG, ITLN
- Daily Record News Briefs: January 9, 2009
Jan 09, 2009 12:57 AM | CEG, DDR, NUVA, OSIR
- Biotech Cools Off in August But Capital Markets Remain Positive
Sep 01, 2009 02:57 PM | EBS, HGSI, ONXX, OSIR
- Biotech Cools Off in August But Capital Markets Remain Positive
Sep 01, 2009 12:57 PM | EBS, HGSI, ONXX, OSIR
- SmallCapSentinel.com: Bone Marrow Stem Cell Company Profile Released
Aug 27, 2009 07:01 AM | ASTM, GERN, OSIR
- Osiris Therapeutics Reports Second Quarter 2009 Financial Results
Aug 06, 2009 08:19 AM | OSIR
- Osiris Therapeutics Creates Biosurgery Division
Aug 04, 2009 05:33 PM | OSIR
- Osiris Achieves Milestone Payment for Progress Developing Stem Cell Therapy for Type 1 Diabetes
Jul 28, 2009 07:01 AM | OSIR
- Osiris Therapeutics Announces Second Quarter 2009 Financial Results Conference Call
Jul 27, 2009 09:17 AM | OSIR
- Genzyme Delivers Solid Second-Quarter Financial Results
Jul 22, 2009 09:56 AM | GENZ, ISIS, OSIR
- Osiris Therapeutics Reports Interim Data for COPD Stem Cell Study
Jun 23, 2009 05:10 PM | OSIR
- Osiris Therapeutics to Present at Piper Jaffray Conference
Jun 17, 2009 05:03 PM | OSIR
- Form 3 Neumayer Matthew Paul For: Nov 06 (10K)
Nov 06, 2009 04:44 PM
- Form 4 Mills C Randal For: Aug 05 (10K)
Aug 05, 2009 12:26 PM
- Form 4 Williams Michelle LeRoux For: Feb 23 (10K)
Feb 25, 2009 06:54 PM
- Form 4 JACOBY PHILIP R JR For: Feb 23 (10K)
Feb 25, 2009 06:54 PM
- Form 4 Debrabandere Lode For: Feb 23 (10K)
Feb 25, 2009 06:54 PM
- Form 4 Hunt Richard W For: Feb 23 (10K)
Feb 25, 2009 06:54 PM
- Form 4 Mills C Randal For: Feb 23 (10K)
Feb 25, 2009 06:54 PM
- Form 4 BARNHILL GREGORY HURD For: Feb 23 (10K)
Feb 25, 2009 06:54 PM
- Form 4 MOYES JAY M For: Feb 23 (10K)
Feb 25, 2009 06:51 PM
- Form 4 Gutzwiller Felix For: Feb 23 (10K)
Feb 25, 2009 06:51 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
OSIR
|
Compare to S&P
|
| YTD |
-64.25 %
|
-70.47 %
|
| 4 Weeks |
-2.56 %
|
-3.08 %
|
| 12 Weeks |
-44.08 %
|
-47.53 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 19.23 %
|
|
EPS Growth in Last Year: 66.67 %
|
|
Sales Growth in Last Quarter: 1.10 %
|
|
Sales Growth in Last Quarter: 963.72 %
|
|
